They offered many explanations for this decision, some of which were unabashedly self-interested — Trump had promised to limit regulatory scrutiny of their companies and taxation of their capital. But ...

In a world with too much noise and too little context, Vox helps you make sense of the news. We don’t flood you with panic-inducing headlines or race to be first. We focus on being useful to you ...

In a world with too much noise and too little context, Vox helps you make sense of the news. We don’t flood you with panic-inducing headlines or race to be first. We focus on being useful to you ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of $32.00. The company’s shares closed yesterday ...

Key suits were filed by third party mRNA and lipid pioneers that, while not having any mRNA-based products on the market themselves, leveraged their patent portfolios claiming a share of the ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other best long term growth stocks to buy according to billionaires. As per Barclays, the US ...

Has Vox Royalty Corp. (VOXR) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out. Vox Royalty Corp. is one of 232 individual stocks in ...

Ricky O'Donnell has covered basketball at all levels for more than a decade at SB Nation. He's currently the Associate Director of Programing. March Madness is over, and the Florida Gators are ...

The surprise delay is casting new uncertainty on the fate of another vaccine awaiting FDA action: Moderna’s next-generation Covid-19 shot, called mRNA-1283, which is set for a decision by May 31.

‘Before asking for more Headcount and resources, teams must demonstrate why they cannot get what they want done using AI.’ ‘Before asking for more Headcount and resources, teams must ...

Ethris and Lonza agreed to collaborate on the development of room-temperature stable, spray-dried formulations of mRNA-based vaccine candidates, designed for mucosal delivery to combat respiratory ...

There's been CAR T therapy for cancers. There's been gene therapy. There's mRNA vaccines, and now there's these GLP-1 anti-obesity, anti-diabetes drugs. All of them - all five of them - were ...